- Home
- XENE vs UAA Comparison
XENE vs UAA Comparison
Compare XENE & UAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XENE
- UAA
- Stock Information
- Founded
- XENE 1996
- UAA 1996
- Country
- XENE Canada
- UAA United States
- Employees
- XENE N/A
- UAA N/A
- Industry
- XENE Biotechnology: Pharmaceutical Preparations
- UAA Apparel
- Sector
- XENE Health Care
- UAA Consumer Discretionary
- Exchange
- XENE Nasdaq
- UAA Nasdaq
- Market Cap
- XENE 2.5B
- UAA 2.5B
- IPO Year
- XENE 2014
- UAA N/A
- Fundamental
- Price
- XENE $35.54
- UAA $6.00
- Analyst Decision
- XENE Strong Buy
- UAA Hold
- Analyst Count
- XENE 9
- UAA 20
- Target Price
- XENE $56.22
- UAA $8.07
- AVG Volume (30 Days)
- XENE 862.0K
- UAA 13.5M
- Earning Date
- XENE 05-12-2025
- UAA 05-13-2025
- Dividend Yield
- XENE N/A
- UAA N/A
- EPS Growth
- XENE N/A
- UAA N/A
- EPS
- XENE N/A
- UAA N/A
- Revenue
- XENE N/A
- UAA $5,315,924,000.00
- Revenue This Year
- XENE N/A
- UAA N/A
- Revenue Next Year
- XENE $1,553.36
- UAA N/A
- P/E Ratio
- XENE N/A
- UAA N/A
- Revenue Growth
- XENE N/A
- UAA N/A
- 52 Week Low
- XENE $26.74
- UAA $4.78
- 52 Week High
- XENE $46.00
- UAA $11.89
- Technical
- Relative Strength Index (RSI)
- XENE 49.08
- UAA 51.48
- Support Level
- XENE $37.46
- UAA $5.61
- Resistance Level
- XENE $39.01
- UAA $6.10
- Average True Range (ATR)
- XENE 1.68
- UAA 0.22
- MACD
- XENE -0.14
- UAA 0.06
- Stochastic Oscillator
- XENE 48.59
- UAA 65.44
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
About UAA Under Armour Inc.
Under Armour develops, markets, and distributes athletic apparel, footwear, and accessories in North America, Asia-Pacific, Europe, and elsewhere. Consumers of its performance-based clothing and shoes include professional and amateur athletes, sponsored college and professional teams, and people with active lifestyles. The company sells merchandise through direct-to-consumer, including e-commerce and more than 400 combined factory house and brand house stores, and wholesale channels. The Baltimore-based company was founded in 1996 and is led by controlling shareholder Kevin Plank.